Journal Article > CommentaryFull Text
BMJ Glob Health. 1 April 2022; Volume 7 (Issue 4); e009010.; DOI:10.1136/bmjgh-2022-009010
Lazarus JV, Abdool Karim SS, van Selm L, Doran J, Batista C, et al.
BMJ Glob Health. 1 April 2022; Volume 7 (Issue 4); e009010.; DOI:10.1136/bmjgh-2022-009010
SUMMARY BOX
-- There has been open and closed vial COVID-19 vaccine wastage in low-income, middle-income and high-income countries, with wastage rates of up to 30%.
-- Plans to monitor, forecast and ultimately reduce vaccine wastage are urgently needed in every country.
-- Open vial wastage should be reduced by strategies increasing overall vaccination rates, such as overbooking appointments and appointment-free vaccination, as well as through technologies maximising the number of doses being extracted from the vial.
-- Closed vial wastage should be reduced by timely, well-organised surplus donations and reallocations, as well as supporting effective supply chain management in recipient countries.
-- There has been open and closed vial COVID-19 vaccine wastage in low-income, middle-income and high-income countries, with wastage rates of up to 30%.
-- Plans to monitor, forecast and ultimately reduce vaccine wastage are urgently needed in every country.
-- Open vial wastage should be reduced by strategies increasing overall vaccination rates, such as overbooking appointments and appointment-free vaccination, as well as through technologies maximising the number of doses being extracted from the vial.
-- Closed vial wastage should be reduced by timely, well-organised surplus donations and reallocations, as well as supporting effective supply chain management in recipient countries.